GODAVARIB — Godavari Biorefineries Balance Sheet
0.000.00%
- IN₹8.56bn
- IN₹14.98bn
- IN₹16.87bn
Annual balance sheet for Godavari Biorefineries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 138 | 138 | 100 | 213 | 111 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,912 | 2,047 | 2,055 | 2,448 | 2,215 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,444 | 7,027 | 9,794 | 8,243 | 10,765 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,514 | 7,163 | 7,106 | 8,738 | 8,654 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 14,345 | 14,417 | 17,335 | 17,435 | 19,917 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,709 | 6,498 | 9,189 | 7,684 | 11,097 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 10,074 | 9,878 | 12,605 | 12,541 | 14,910 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 4,271 | 4,539 | 4,730 | 4,894 | 5,007 |
Total Liabilities & Shareholders' Equity | 14,345 | 14,417 | 17,335 | 17,435 | 19,917 |
Total Common Shares Outstanding |